279 related articles for article (PubMed ID: 1997510)
1. Plasma intact parathyroid hormone (PTH) and PTH-related peptide in familial benign hypercalcemia: greater responsiveness to endogenous PTH than in primary hyperparathyroidism.
Firek AF; Kao PC; Heath H
J Clin Endocrinol Metab; 1991 Mar; 72(3):541-6. PubMed ID: 1997510
[TBL] [Abstract][Full Text] [Related]
2. Calcium regulation of parathyroid and C cell function in familial benign hypercalcemia.
Rajala MM; Klee GG; Heath H
J Bone Miner Res; 1991 Feb; 6(2):117-24. PubMed ID: 2028833
[TBL] [Abstract][Full Text] [Related]
3. Urinary cyclic 3',5'-adenosine monophosphate responses to exogenous and endogenous parathyroid hormone in familial benign hypercalcemia and primary hyperparathyroidism.
Heath H; Purnell DC
J Lab Clin Med; 1980 Dec; 96(6):974-84. PubMed ID: 6253580
[TBL] [Abstract][Full Text] [Related]
4. Cyclic adenosine 3',5'-monophosphate responses to parathyroid hormone, prostaglandin E2, and isoproterenol in dermal fibroblasts from patients with familial benign hypercalcemia.
Firek AF; Carter WB; Heath H
J Clin Endocrinol Metab; 1991 Jul; 73(1):203-6. PubMed ID: 1710622
[TBL] [Abstract][Full Text] [Related]
5. Hyperprolactinemia caused by lactation and pituitary adenomas is associated with altered serum calcium, phosphate, parathyroid hormone (PTH), and PTH-related peptide levels.
Kovacs CS; Chik CL
J Clin Endocrinol Metab; 1995 Oct; 80(10):3036-42. PubMed ID: 7559893
[TBL] [Abstract][Full Text] [Related]
6. Vitamin D metabolism in familial benign hypercalcemia (hypocalciuric hypercalcemia) differs from that in primary hyperparathyroidism.
Law WM; Bollman S; Kumar R; Heath H
J Clin Endocrinol Metab; 1984 Apr; 58(4):744-7. PubMed ID: 6699136
[TBL] [Abstract][Full Text] [Related]
7. Circulating parathyroid hormone activity: familial hypocalciuric hypercalcemia versus typical primary hyperparathyroidism.
Marx SJ; Spiegel AM; Brown EM; Windeck R; Gardner DG; Downs RW; Attie M; Aurbach GD
J Clin Endocrinol Metab; 1978 Dec; 47(6):1190-7. PubMed ID: 233692
[TBL] [Abstract][Full Text] [Related]
8. Urine calcium and serum ionized calcium, total calcium and parathyroid hormone concentrations in the diagnosis of primary hyperparathyroidism and familial benign hypercalcaemia.
Gunn IR; Wallace JR
Ann Clin Biochem; 1992 Jan; 29 ( Pt 1)():52-8. PubMed ID: 1536526
[TBL] [Abstract][Full Text] [Related]
9. Kinetics of erythrocyte plasma membrane (Ca2+, Mg2+)ATPase in familial benign hypercalcemia.
Donahue HJ; Penniston JT; Heath H
J Clin Endocrinol Metab; 1989 May; 68(5):893-8. PubMed ID: 2523897
[TBL] [Abstract][Full Text] [Related]
10. Distribution of serum calcium values in patients with familial benign hypercalcemia (hypocalciuric hypercalcemia): evidence for a discrete genetic defect.
Rajala MM; Heath H
J Clin Endocrinol Metab; 1987 Nov; 65(5):1039-41. PubMed ID: 3667874
[TBL] [Abstract][Full Text] [Related]
11. Parathyroid hormone-related protein: elevated levels in both humoral hypercalcemia of malignancy and hypercalcemia complicating metastatic breast cancer.
Grill V; Ho P; Body JJ; Johanson N; Lee SC; Kukreja SC; Moseley JM; Martin TJ
J Clin Endocrinol Metab; 1991 Dec; 73(6):1309-15. PubMed ID: 1955513
[TBL] [Abstract][Full Text] [Related]
12. Immunochemical characterization of circulating parathyroid hormone-related protein in patients with humoral hypercalcemia of cancer.
Burtis WJ; Brady TG; Orloff JJ; Ersbak JB; Warrell RP; Olson BR; Wu TL; Mitnick ME; Broadus AE; Stewart AF
N Engl J Med; 1990 Apr; 322(16):1106-12. PubMed ID: 2320080
[TBL] [Abstract][Full Text] [Related]
13. Contribution of parathyroid hormone-related peptide to the evaluation of hypercalcemia.
Audran M; Minebois-Villégas A; Lortholary A; Legrand E; Pascaretti C; Giraud P; Subra JF; Boasson M; Jallet P
Rev Rhum Engl Ed; 1995 Mar; 62(3):189-96. PubMed ID: 7788336
[TBL] [Abstract][Full Text] [Related]
14. [Clinical studies using a highly sensitive radioimmunoassay for mid-region and carboxy terminus of parathyroid hormone in normal, hypo- and hypercalcemic states].
Fukase M; Fujita T; Matsumoto T; Ogata E; Iijima T; Takezawa J; Saito K; Ishige H; Fujimoto M
Nihon Naibunpi Gakkai Zasshi; 1989 Aug; 65(8):807-27. PubMed ID: 2553507
[TBL] [Abstract][Full Text] [Related]
15. Effects of treatment of malignancy-associated hypercalcemia on serum parathyroid hormone-related protein.
Budayr AA; Zysset E; Jenzer A; Thiébaud D; Ammann P; Rizzoli R; Jaquet-Müller F; Bonjour JP; Gertz B; Burckhardt P
J Bone Miner Res; 1994 Apr; 9(4):521-6. PubMed ID: 8030440
[TBL] [Abstract][Full Text] [Related]
16. Parathyroid hormone (PTH)-related protein, PTH, and 1,25-dihydroxyvitamin D in dogs with cancer-associated hypercalcemia.
Rosol TJ; Nagode LA; Couto CG; Hammer AS; Chew DJ; Peterson JL; Ayl RD; Steinmeyer CL; Capen CC
Endocrinology; 1992 Sep; 131(3):1157-64. PubMed ID: 1505457
[TBL] [Abstract][Full Text] [Related]
17. Circulating PTH and PTHrP levels before and after treatment of tumor induced hypercalcemia with Pamidronate Disodium (APD).
Grill V; Murray RM; Ho PW; Santamaria JD; Pitt P; Potts C; Jerums G; Martin TJ
J Clin Endocrinol Metab; 1992 Jun; 74(6):1468-70. PubMed ID: 1592895
[TBL] [Abstract][Full Text] [Related]
18. Role of assays for parathyroid-hormone-related protein in investigation of hypercalcaemia.
Ratcliffe WA; Hutchesson AC; Bundred NJ; Ratcliffe JG
Lancet; 1992 Jan; 339(8786):164-7. PubMed ID: 1346019
[TBL] [Abstract][Full Text] [Related]
19. Use of C-terminal parathyroid assays in a large metropolitan hospital.
Lum G
Ann Clin Lab Sci; 1985; 15(1):55-60. PubMed ID: 3970518
[TBL] [Abstract][Full Text] [Related]
20. Familial benign hypercalcaemia.
Paterson CR; Gunn A
Lancet; 1981 Jul; 2(8237):61-3. PubMed ID: 6113439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
